Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials

Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy

(2013) Candice M. Wenzell et al.   SUPPORTIVE CARE IN CANCER

Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis

(2012) Y. JIN et al.   EUROPEAN JOURNAL OF CANCER CARE

Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy

(2012) Joseph A. Roscoe et al.   JOURNAL OF CLINICAL ONCOLOGY

A Systematic Review and Meta-Analysis of Intravenous Palonosetron in the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults

(2011) Z. Likun et al.   ONCOLOGIST

Update and new trends in antiemetic therapy: the continuing need for novel therapies

(2010) P. Feyer et al.   ANNALS OF ONCOLOGY

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

(2010) F. Roila et al.   ANNALS OF ONCOLOGY

Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia

(2010) Gloria N. Mattiuzzi et al.   CANCER

Palonosetron for prevention of acute and delayed nausea and vomiting in non-small-cell lung carcinoma patients

(2010) Xiaorong Dong et al.   MEDICAL ONCOLOGY

Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population

(2010) Weihua Tian et al.   MEDICAL ONCOLOGY

Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis

(2010) Tobias Engel Ayer Botrel et al.   SUPPORTIVE CARE IN CANCER

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

(2009) Mitsue Saito et al.   LANCET ONCOLOGY

Palonosetron Hydrochloride Is an Effective and Safe Option to Prevent Chemotherapy-induced Nausea and Vomiting in Children

(2008) Ana Carolina Sepúlveda-Vildósola et al.   ARCHIVES OF MEDICAL RESEARCH

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

(2008) Zhaocai Yu et al.   SUPPORTIVE CARE IN CANCER